Wada N.I., Jacobson L.P., Margolick J.B., Breen E.C., Macatangay B., Penugonda S., Martínez-Maza O., Bream J.H. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS, 2015, Vol. 29, No. 4, рр. 463–471. DOI: 10.1097/QAD.0000000000000545. URL: http://journals.lww.com/aidsonline/Fulltext/2015/02200/The_effect_of_HAART_induced_HIV_suppression_on.8.aspx..
DOI: 10.1097/QAD.0000000000000545http://journals.lww.com/aidsonline/Fulltext/2015/02200/The_effect_of_HAART_induced_HIV_suppression_on.8.aspx
Cortez K.J., Maldarelli F. Clinical Management of HIV Drug Resistance. Viruses, 2011, Vol. 3, No. 4, pp. 347–378. DOI: 10.3390/v3040347. URL: http://www.mdpi.com/1999–4915/3/4/347..
DOI: 10.3390/v3040347http://www.mdpi.com/1999–4915/3/4/347
French M.A., Cozzi-Lepri A., Arduino R.C., Johnson M., Achhra A.C., Landay A. Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case–control analysis nested in a large clinical trial. AIDS, 2015, Vol. 29, No. 7, pp. 847–851. DOI: 10.1097/QAD.0000000000000618. URL: http://journals.lww.com/aidsonline/Fulltext/2015/04240/Plasma_levels_of_cytokines_and_chemokines_and_the.12.aspx..
DOI: 10.1097/QAD.0000000000000618http://journals.lww.com/aidsonline/Fulltext/2015/04240/Plasma_levels_of_cytokines_and_chemokines_and_the.12.aspx
Кабаков Р.И. R в действии. Анализ и визуализация данных в программе R / Пер. с англ. П.А.Волковой. М.: ДМК Пресс, 2014. 588 с. [Kabakov R.I. R in action. Analysis and visualization of data in the program R. Ed. P.A.Volkova. Moscow: DMK Press, 2014. 588 p. (In Russ.)].
Flach P. Machine Learning. The Art and Science of Algorithms that make Sense of Data. Cambridge University Press, 2012, 396 p.
Hyndman R.J., Athanasopoulos G. Forecasting: principles and practice. O Texts, 2013. URL: https://www.otexts.org/1461 (September 30, 2017).https://www.otexts.org/1461
Бобкова М.Р. Лекарственная устойчивость ВИЧ. М.: Человек, 2014. 288 с. [Bobkova M.R. Drug resistance of HIV. Moscow: Chelovek, 2014, 288 p. (In Russ.)].
Селимова Л.М., Серебровская Л.В., Иванова Л.А., Носик Д.Н. Показатели CD4+ и CD8+ Т-лимфоцитов пациентов, инфицированных вариантами вируса иммунодефицита человека 1- го типа подтипа А, несущими мутации V77I в протеазе и A62V в обратной транскриптазе // Вопросы вирусологии. 2010. № 2. С. 22–26. URL: http://www.medcollegelib.ru/doc/0507–40882-SCN0004.html. [Selimova L.M., Serebrovskaya L.V., Ivanova L.A., Nosik D.N. Indicators CD4+ and CD8+ T-lymphocytes of patients infected with variants of human immunodeficiency virus 1-th type, subtype And carrying mutations V77I in protease and A62V in reverse transcriptase. Problems of Virology, 2010, No. 2, C. 22–26. URL: http://www.medcollegelib.ru/doc/0507–40882-SCN0004.html (In Russ.)].http://www.medcollegelib.ru/doc/0507–40882-SCN0004.html
Селимова Л.М., Серебровская Л.В., Иванова Л.А., Носик Д.Н. Показатели CD4+ и CD8+ Т-лимфоцитов пациентов, инфицированных вариантами вируса иммунодефицита человека 1- го типа подтипа А, несущими мутации V77I в протеазе и A62V в обратной транскриптазе // Вопросы вирусологии. 2010. № 2. С. 22–26. URL: http://www.medcollegelib.ru/doc/0507–40882-SCN0004.html. [Selimova L.M., Serebrovskaya L.V., Ivanova L.A., Nosik D.N. Indicators CD4+ and CD8+ T-lymphocytes of patients infected with variants of human immunodeficiency virus 1-th type, subtype And carrying mutations V77I in protease and A62V in reverse transcriptase. Problems of Virology, 2010, No. 2, C. 22–26. URL: http://www.medcollegelib.ru/doc/0507–40882-SCN0004.html (In Russ.)].http://www.medcollegelib.ru/doc/0507–40882-SCN0004.html
Armah K.A., McGinnis K., Baker J., Gibert C., Butt A.A., Bryant K.J. et al. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin. Infect. Dis., 2012, No. 55, pp. 126–136. DOI: 10.1093/cid/cis406 http://paperity.org/p/42769640/hiv-status-burden-of-comorbid-disease-and-biomarkers-of-inflammation-altered-coagulation..
DOI: 10.1093/cid/cis406http://paperity.org/p/42769640/hiv-status-burden-of-comorbid-disease-and-biomarkers-of-inflammation-altered-coagulation
Шмагель К.В., Шмагель Н.Г., Черешнев В.А. Активация иммунитета при ВИЧ-инфекции // Медицинская иммунология. 2017. Т. 19, № 5. С. 489–504. DOI: 10.15789/1563-0625-2017-5-489-504. URL: http://mimmun.ru/mimmun/article/view/1348/964. [Shmagel K.V., Shmagel N.G., Chereshnev V.A. Activation of the immune system in HIV infection. Medical Immunology, 2017, Vol. 19, No. 5, pp. 489–504. DOI: 10.15789/1563-0625-2017-5-489-504. URL: http://mimmun.ru/mimmun/article/view/1348/964 (In Russ.)]..
DOI: 10.15789/1563-0625-2017-5-489-504http://mimmun.ru/mimmun/article/view/1348/964
Шмагель К.В., Шмагель Н.Г., Черешнев В.А. Активация иммунитета при ВИЧ-инфекции // Медицинская иммунология. 2017. Т. 19, № 5. С. 489–504. DOI: 10.15789/1563-0625-2017-5-489-504. URL: http://mimmun.ru/mimmun/article/view/1348/964. [Shmagel K.V., Shmagel N.G., Chereshnev V.A. Activation of the immune system in HIV infection. Medical Immunology, 2017, Vol. 19, No. 5, pp. 489–504. DOI: 10.15789/1563-0625-2017-5-489-504. URL: http://mimmun.ru/mimmun/article/view/1348/964 (In Russ.)]..
DOI: 10.15789/1563-0625-2017-5-489-504http://mimmun.ru/mimmun/article/view/1348/964
Кетлинский C.A., Симбирцев А.С. Цитокины. СПб.: Фолиант, 2008. 552 с. [Ketlinskiy S.A., Simbirtsev A.S. Cytokines. Saint-Petersburg: Foliant, 2008, 552 p. (In Russ.)].
Wilson K.C., Center D.M., Cruikshank W.W. The effect of interleukin-16 and its precursor on T lymphocyte activation and growth. Growth Factors, 2004, No. 22 (2), pp. 97–104. PMID: 15253385. URL: https://pdfs.semanticscholar.org/b285/78bd90242858d2b607836ff329816be45920.pdf.https://pdfs.semanticscholar.org/b285/78bd90242858d2b607836ff329816be45920.pdf
Amiel C., Darcissac E., Tuong M., Dewulf J., Loyens M., Mouton Y., Capron A., Bahr G.M. Interleukin-16 (IL16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression. J. Infect. Dis., 1999, No. 179, pp. 83–91. DOI: 10.1086/314550. URL: http://paperity.org/p/58504903/interleukin-16-il-16-inhibits- human-immunodeficiency-virus-replicationin-cells-from..
DOI: 10.1086/314550http://paperity.org/p/58504903/interleukin-16-il-16-inhibits-
Baier M., Werner A., Bannert N., Metzner K., Kurth R. HIV suppression by interleukin-16. Nature, 1995, No. 378, pp. 563. DOI: 10.1038/378563a0. URL: https://www.nature.com/articles/378563a0..
DOI: 10.1038/378563a0https://www.nature.com/articles/378563a0
Bisset L.R., Rothen M., Joller-Jemelka H.I., Dubs R.W., Grob P.J., Opravil M. Change in circulating levels of the chemokines macrophage inflammatory proteins 1a and 1b, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV- infected patients with indinavir. AIDS, 1997, No. 11, pp. 485–491. PMID: 9084796. URL: http://journals.lww.com/aidsonline/Fulltext/1997/04000/Change_in_circulating_levels_of_the_chemokines.12.aspx.http://journals.lww.com/aidsonline/Fulltext/1997/04000/Change_in_circulating_levels_of_the_chemokines.12.aspx
Bader A., Brockmeyer N., Schnaitmann E., Mertins L. et al. Interleukin-16 serum levels during the course of HIV-1 infection. AIDS, 2001, Vol. 15, Nо. 4, pp. 528–529. PMID: 11242152. URL: http://journals.lww.com/aidsonline/Fulltext/2001/03090/Interleukin_16_serum_levels_during_the_course_of.14.aspx.http://journals.lww.com/aidsonline/Fulltext/2001/03090/Interleukin_16_serum_levels_during_the_course_of.14.aspx
Chun T.W., Justement J.S., Moir S., Hallahan C.W., Ehler L.A., Liu S., McLaughlin M., Dybul M., Mican J.M., Fauci A.S. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies. Proc. Natl. Acad. Sci. USA, 2001, No. 98, pp. 253–258. DOI: 10.1073/pnas.98.1.253. URL: https://www.pubfacts.com/detail/11136258/Suppression-of-HIV-replication-in-the-resting-CD4-T- cell-reservoir-by-autologous-CD8-T-cells-implica..
DOI: 10.1073/pnas.98.1.253https://www.pubfacts.com/detail/11136258/Suppression-of-HIV-replication-in-the-resting-CD4-T-
Center D.M., Kornfeld H., Ryan T.C., Cruikshank W.W. Interleukin 16: implications for CD4 functions and HIV-1 progression. Immunol. Today, 2000, No. 21 (6), pp. 273–280. PMID: 10825739. URL: https://www.ncbi.nlm.nih.gov/pubmed/term=Center+D.M.[%]2C+Kornfeld+H.[%]2C+Ryan+T.C.[%]2C+Cruikshank+W.W.+Interleukin+16[%]3A+implications+for+CD4+functions+and+HIV1+progression+[%]2F[%]2F+Immunol.+Today[%]2C+2000[%]2C+[%]E2[%]84[%]96+21(6)[%]2C+pp.+273–80.+PMID[%]3A+10825739.https://www.ncbi.nlm.nih.gov/pubmed/term=Center+D.M.[%]2C+Kornfeld+H.[%]2C+Ryan+T.C.[%]2C+Cruikshank+W.W.+Interleukin+16[%]3A+implications+for+CD4+functions+and+HIV1+progression+[%]2F[%]2F+Immunol.+Today[%]2C+2000[%]2C+[%]E2[%]84[%]96+21(6)[%]2C+pp.+273–80.+PMID[%]3A+10825739
Попкова Т.В., Новикова Д.С., Насонов Е.Л. Интерлейкин 6 и сердечно-сосудистая патология при ревматоидном артрите // Научно-практиче-
ская ревматология. 2011. № 4. С. 64–72. DOI: http://dx.doi.org/10.14412/1995-4484-2011-63. URL: https://cyberleninka.ru/article/n/interleykin-.
DOI: 10.14412/1995-4484-2011-63https://cyberleninka.ru/article/n/interleykin-
-i-serdechno-sosudistaya-patologiya-pri-revmatoidnom-artrite. [Popkova T.V., Novikova D.S., Nasonov E.L. Interleukin-6 and cardiovascular
disease in rheumatoid arthritis. Scientific-Practical Rheumatology, 2011, No. 4, pp. 64–72. DOI: http://dx.doi.org/10.14412/1995-4484-2011-63..
DOI: 10.14412/1995-4484-2011-63
URL: https://cyberleninka.ru/article/n/interleykin-6-i-serdechno-sosudistaya-patologiya-pri-revmatoidnom-artrite (In Russ.)].https://cyberleninka.ru/article/n/interleykin-6-i-serdechno-sosudistaya-patologiya-pri-revmatoidnom-artrite
Орадова А.Ш., Канжигалина З.К., Касенова Р.К. Лабораторная диагностика цитокинов (обзорная статья) // Вестник Казахского государственного
медицинского университета. 2015. № 1. С. 357–359. URL: https://cyberleninka.ru/article/n/laboratornaya-diagnostika-tsitokinov-obzornaya-statya-1.https://cyberleninka.ru/article/n/laboratornaya-diagnostika-tsitokinov-obzornaya-statya-1
[Orazova A.Sh., Kanzhigalina Z.K., Kasenova R.K. Laboratory diagnostics of cytokines (review article). Bulletin of Kazakh State Medical University, 2015, No. 1, pp. 357–359. URL: https://cyberleninka.ru/article/n/laboratornaya-diagnostika-tsitokinov-obzornaya-statya-1 (In Russ.)].https://cyberleninka.ru/article/n/laboratornaya-diagnostika-tsitokinov-obzornaya-statya-1
Белова О.В., Арион В.Я., Сергиенко В.И. Роль цитокинов в иммунологической функции кожи // Иммунопатология, аллергология, инфектология. 2008. № 1. С. 41–55. URL: http://www.immunopathology.com/ru/article.php?carticle=6. [Belova O.V., Arion V.Ya., Sergienko V.I. Role of cytokines in immunological function of skin. Immunopathology, Allergology, Infectology, 2008, No. 1, pp. 41–55. URL: http://www.immunopathology.com/ru/article.php?carticle=6 (In Russ.)].http://www.immunopathology.com/ru/article.php?carticle=6
Белова О.В., Арион В.Я., Сергиенко В.И. Роль цитокинов в иммунологической функции кожи // Иммунопатология, аллергология, инфектология. 2008. № 1. С. 41–55. URL: http://www.immunopathology.com/ru/article.php?carticle=6. [Belova O.V., Arion V.Ya., Sergienko V.I. Role of cytokines in immunological function of skin. Immunopathology, Allergology, Infectology, 2008, No. 1, pp. 41–55. URL: http://www.immunopathology.com/ru/article.php?carticle=6 (In Russ.)].http://www.immunopathology.com/ru/article.php?carticle=6
Вирус иммунодефицита человека — медицина / Под ред. Н.А.Белякова и А.Г.Рахмановой. СПб.: Балтийский медицинский образовательный центр, 2010. 752 с. [The human immunodeficiency virus — medicine. Eds. N.A.Belyakov and A.G.Rakhmanova. Saint-Petersburg.: Baltic medical education center, 2010, 752 p. (In Russ.)].
Федяева О.Н., Ющук Н.Д., Сирота Н.А. Прогнозирование приверженности антиретровирусной терапии у пациентов с ВИЧ-инфекцией // Казанский медицинский журнал. 2014. № 5. С. 715–721. URL: https://cyberleninka.ru/article/n/prognozirovanie- priverzhennosti-antiretrovirusnoy-terapii-u-patsientov-s-vich-infektsiey. [Fedyaeva O.N., Yushchuk N.D., Sirota N.A. Prediction of adherence to antiretroviral therapy in patients with HIV infection. Kazan Medical Journal, 2014, No. 5, pp. 715–721. URL: https://cyberleninka.ru/article/n/prognozirovanie-priverzhennosti-antiretrovirusnoy-terapii-u-patsientov-s-vich-infektsiey (In Russ.)].https://cyberleninka.ru/article/n/prognozirovanie-
Федяева О.Н., Ющук Н.Д., Сирота Н.А. Прогнозирование приверженности антиретровирусной терапии у пациентов с ВИЧ-инфекцией // Казанский медицинский журнал. 2014. № 5. С. 715–721. URL: https://cyberleninka.ru/article/n/prognozirovanie- priverzhennosti-antiretrovirusnoy-terapii-u-patsientov-s-vich-infektsiey. [Fedyaeva O.N., Yushchuk N.D., Sirota N.A. Prediction of adherence to antiretroviral therapy in patients with HIV infection. Kazan Medical Journal, 2014, No. 5, pp. 715–721. URL: https://cyberleninka.ru/article/n/prognozirovanie-priverzhennosti-antiretrovirusnoy-terapii-u-patsientov-s-vich-infektsiey (In Russ.)].https://cyberleninka.ru/article/n/prognozirovanie-priverzhennosti-antiretrovirusnoy-terapii-u-patsientov-s-vich-infektsiey
Kuller L.H., Tracy R., Belloso W., De Wit S., Drummond F., Lane H.C., Ledergerber B., Lundgren J., Neuhaus J., Nixon D., Paton N.I., Neaton J.D. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med., 2008, Vol. 5, No. 10, pp. 203. DOI: 10.1371/journal.pmed.0050203. URL: https://www.ncbi.nlm.nih.gov/pubmed/18942885..
DOI: 10.1371/journal.pmed.0050203https://www.ncbi.nlm.nih.gov/pubmed/18942885
Volpato S., Guralnik J.M., Ferrucci L., Balfour J., Chaves P., Fried L.P., Harris T.B. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women’s health and aging study. Circulation, 2001, Vol. 103, No. 7, pp. 947–953. PMID: 11181468. URL: http://circ.ahajournals.org/content/103/7/947.http://circ.ahajournals.org/content/103/7/947
Hartman J., Frishman W.H. Inflammation and Atherosclerosis: A Review of the Role of Interleukin-6 in the Development of Atherosclerosis and the Potential for Targeted Drug Therapy. Cardiology in Review, 2014, Vol. 22, No. 3, pp. 147–151. DOI:10.1097/CRD.0000000000000021. URL: https://www.sema-nticscholar.org/paper/Inflammation-and-atherosclerosis-a-review-of-the-r-Hartman-Frishman/ 9103e48e127cc895869009de43255665f22e8e3f..
DOI: 10.1097/CRD.0000000000000021https://www.sema-nticscholar.org/paper/Inflammation-and-atherosclerosis-a-review-of-the-r-Hartman-Frishman/
Hamlyn E., Fidler S., Stöhr W., Cooper D.A., Tambussi G., Schechter M., Miro J.M., Mcclure M., Weber J., Babiker A., Porter K. Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression. AIDS, 2014, Vol. 28, No. 6, pp. 869–874. DOI: 10.1097/QAD.0000000000000155. URL: http://journals.lww.com/aidsonline/Fulltext/2014/03270/Interleukin_6_and_D_dimer_levels_at_seroconversion.8.aspx..
DOI: 10.1097/QAD.0000000000000155http://journals.lww.com/aidsonline/Fulltext/2014/03270/Interleukin_6_and_D_dimer_levels_at_seroconversion.8.aspx
Hamlyn E., Fidler S., Stöhr W., Cooper D.A., Tambussi G., Schechter M., Miro J.M., Mcclure M., Weber J., Babiker A., Porter K. Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression. AIDS, 2014, Vol. 28, No. 6, pp. 869–874. DOI: 10.1097/QAD.0000000000000155. URL: http://journals.lww.com/aidsonline/Fulltext/2014/03270/Interleukin_6_and_D_dimer_levels_at_seroconversion.8.aspx..
DOI: 10.1097/QAD.0000000000000155http://journals.lww.com/aidsonline/Fulltext/2014/03270/Interleukin_6_and_D_dimer_levels_at_seroconversion.8.aspx